MedPath

Intravenous Infusion of Lidocaine in ERCP

Phase 4
Conditions
Sedation
Interventions
Drug: placebo
Registration Number
NCT03996577
Lead Sponsor
Shandong University
Brief Summary

Intravenous infusion of lidocaine significantly reduces propofol dose for ERCP and improve patients' recovery after ERCP.

Detailed Description

This study divide patients into two groups, one will be given lidocaine; another group was given placebo . to observe two groups of patients blood pressure, body movement, and propofol dosage , and the difference in operator satisfaction, and how many people need to give fentanyl again; and two groups of patients after the operation of the reaction, if there are dizziness, nausea, and other adverse reactions; finally, the differences of these two schemes in different populations were analyzed, and the rationalization and individualized medication will be put forward.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria

Inpatients aged >18 years who were scheduled for ERCP at Qilu hospital.

Exclusion Criteria
  • Patients with ASA class 4 or 5,
  • Patients with pre-existing hypoxaemia (SpO2<90%),
  • Patients with hypotension (SBP<90mmHg)
  • Patients with bradycardia (HR<50 bpm)
  • patients with severe chronic renal failure (creatinine clearance<30 ml/min)
  • patients with uncontrolled hypertension (systolic blood pressure>170 mm Hg, diastolic blood pressure>100 mm Hg)
  • patients with pregnancy or lactation
  • Patients hemodynamically unstable
  • Patients unable to give informed consent
  • Patients with a history of drug allergies;

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
control groupplacebothe control group will be given the same volume of saline as the experimental group
Experimental: lidocaine groupLidocainethe experimental group will be given l-1.5mg lidocaine and then 2mg/kg/h
Primary Outcome Measures
NameTimeMethod
propofol consumption difference between the two groupshalf a year

the total propofol dosage consumption between the two groups

Secondary Outcome Measures
NameTimeMethod
Safety assessed by the rate of hypoxia during the procedure Safety assessed by the rate of hypoxia during the procedurehalf a year

Hypoxia, defined as peripheral oxygen saturation \<90% for \>30 seconds

Safety assessed by the rate of hypotention during the procedurehalf a year

Hypotension, defined as systolic blood pressure \<90 mmHg

endoscopists satisfaction assessed by the performerhalf a year

the endoscopists satisfacition score were assessed on a 0-10VAS after the procedure

patient satisfaction assessed by the patienthalf a year

the patient satisfacition score were assessed on a 0-10VAS 30mins after the procedure

pain socre after the ERCPhalf a year

pain were measured on a 0-10VAS at arrival in the recovery room ,30min later

fatigue score after the ERCPhalf a year

fatigue were measured on a 0-10VAS at arrival in the recovery room ,30min later

Safety assessed by the rate of breadycardia during the procedurehalf a year

Bradycardia, defined as heart rate \<50 beats/min

Safety assessed by the rate of required airway management during the procedurehalf a year

Required airway management such as jaw lifting, mask ventilation, or tracheal intubation in severe hypoxia Required airway management such as jaw lifting, mask ventilation, or tracheal intubation in severe hypoxia

Safety assessed by the rate of involuntary movement during the procedurehalf a year

Involuntary movements, defined as unconscious movements requiring restraint or severe limb movement interrupting the endoscopy procedure

Trial Locations

Locations (2)

Department of Gastroenterology, Qilu Hospital, Shandong University

🇨🇳

Jinan, Shandong, China

Qilu Hospital of Shandong University

🇨🇳

Jinan, China

© Copyright 2025. All Rights Reserved by MedPath